Bucindolol Significantly Reduces Hospitalization and Death in Heart Failure Patients With Very Favorable... ( Common Genetic Variations Predict P...)

Bucindolol Significantly Reduces Hospitalization and Death in Heart Failure Patients With Very Favorable Genotypes

Date:9/22/2008

Common Genetic Variations Predict Patient Response to Novel Beta Blocker

Therapy

TORONTO, Sept. 22 /PRNewswire/ -- Bucindolol, an investigational, pharmacologically unique beta-blocker and mild vasodilator, significantly reduces hospitalization and death among heart failure patients with very favorable genotypes, according to results of a large DNA study presented today as a poster at the annual meeting of the Heart Failure Society of America. Researchers found that common genetic variations can predict which heart failure patients will have the greatest therapeutic response to bucindolol.

ARCA biopharma has submitted a New Drug Application (NDA) for bucindolol to the U.S. Food and Drug Administration for the treatment of chronic heart failure.

"The ability to predict patient response to bucindolol makes it easier for physicians to match the right patient to the right medicine, potentially avoiding months of trial-and-error therapy and helping very sick heart failure patients achieve better outcomes sooner," said Christopher O'Connor, M.D., Director of the Heart Center at Duke University Medical Center and presenter of the study. "This data brings us much closer to realizing the benefits of personalized medicine in heart failure."

The prospectively-designed DNA sub-study included more than 1,000 patients enrolled in the Beta-Blocker Evaluation of Survival Trial (BEST), the largest heart failure mortality trial conducted primarily in the United States. Researchers evaluated therapeutic response to bucindolol among patients with genetic variations, or polymorphisms, in two adrenergic receptors that help regulate cardiac function: beta 1 389 Arg/Gly and alpha 2c 322-325 WT/Del. Researchers identified three distinct genotypes that predict the effect of bucindolol: very favorable (47% of BEST patients), favorable (40%) and unfavorable (13%).

In the study, patients with the very favorable genotype
'/>"/>

SOURCE ARCA biopharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
2. Phase 2 Data Show Daclizumab Significantly Reduced Multiple Sclerosis Lesions in Patients Receiving Interferon Beta Therapy
3. Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo
4. UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients
5. New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo
6. Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer
7. Cord Blood America CEO Matthew Schissler Says Operations Significantly Streamlined
8. Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources
9. Phase 3 studies show golimumab significantly improved signs and symptoms of rheumatoid arthritis
10. On the boil: New nano technique significantly boosts boiling efficiency
11. Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice

Post Your Comments:

(Date:11/9/2009)...wire/ -- "Micro cap and small cap equities across ...ponsorship and exposure as a ,buying window, opens...driven stocks like gold, silver and other metals,"... Inc, Manhattan based investor relations firm with...arket in the US and Canada, and with expansion pla...

(Date:11/9/2009)...swire-FirstCall/ -- BioMed Realty Trust, Inc. (NYS...eived commitments from lenders to increase the bor... $65 million to an aggregate of $665 million, with...he weighted-average effective interest rate of the...r 30, 2009. The maturity date remains August 1, 20...

(Date:11/9/2009)...Newswire-Asia/ -- The pharma and biotech sectors a...panies are facing significant,pressure to change w..., calls for,lower prices and a greater regulatory ...al crisis have made the work of creating new drugs...e being forced to globalize their R&D,operatio...

(Date:11/9/2009)...ewswire-FirstCall/ -- CEL-SCI Corporation (NYSE Am...enthal, Professor of Immunology and Microbiology o...ne and Pharmacy, reported on work conducted in col... and CEL-SCI on CEL-SCI,s LEAPS vaccine technology...e: "All Things Considered" Conference in Crystal C...

Breaking Biology Technology:Haft Group says Bullish Commodity Market Triggers Small and Micro-cap Upsurge 2 BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 2 BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 3 Pharma and Biotech Leaders to Converge in Shanghai 2 CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2 CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3

[0] Haft Group says Bullish Commodity Market Triggers Small and Micro-cap Upsurge [0] BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million [0] Pharma and Biotech Leaders to Converge in Shanghai [0] CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response

... , , , for amplification of GC-rich t... No. 2 140 306 50 PCR reactions , , , ..., Unique enzyme blend of Taq DNA Polymerase a...me with a proofreading (3,5, exonuclease) , ...includes: , , An optimized GC-R...

... , , , Highly purified deoxynucleotide...vity in all PCR and RT-PCR applications, , ...e with PCR Grade Nucleotides! , Produce sen...oped PCR grade , deoxy-nucleotides from RAS..., RT-PCR assays, even when analyzing low cop...

... , , , for one-step RT-PCR amplificat...016 338 50 reactions , Cat. No. 2 016 346 2...Description , , , The system contains ...rase and Taq DNA Polymerase. , , No... Science is the recombinant , form of the D...

Other Biology Technology:GC-RICH PCR System 2 PCR Grade Deoxynucleotides 2 PCR Grade Deoxynucleotides 3 PCR Grade Deoxynucleotides 4 PCR Grade Deoxynucleotides 5 C. therm. Polymerase One-Step RT-PCR System 2 C. therm. Polymerase One-Step RT-PCR System 3

GC-RICH PCR System PCR Grade Deoxynucleotides C. therm. Polymerase One-Step RT-PCR System

(Date:11/9/2009)... children with cancer, the hopeful news is that pe...decades. Among the bad newstreatments that enable ...osed with cancer who have reached puberty currentl... before undergoing cancer treatment, they may have...Younger boys, however, do not produce sperm, altho...

(Date:11/9/2009)...Ala. The U.S. Department of Energy (DOE) has anno...Alabama at Birmingham (UAB) School of Engineering ...gas emissions through the capture and permanent sa...O2). The project is in collaboration with Southern... Funded by the DOE through the 2009 American Recov...

(Date:11/9/2009)...ournal Naturwissenschaften is publishing a speci...dern Biology" to commemorate Darwin,s On the Origi...November 1859. Guest editor and author of the lead...nt physiology and evolutionary biology at the Univ...special issue are available free of charge until 3...

[0] For young boys with cancer, testicular tissue banking may be option to preserve fertility [0] UAB, partners seek safe carbon dioxide storage for 'greener' power generation [0] Charles Darwin and modern biology

...rus,s hemagglutinin receptor binding site—a molecu...—stopped viral transmission in ferrets, according ...inai School of Medicine and at the Centers for Dis...d in the February 1 issue of Science, could have s...ists develop ways to break the disease cycle and p...

... University of Georgia scientists suggests that cu... do little ?if anything ?to reduce rates of antibi... threaten human health. , Dr. Margie Lee, profess...her colleagues have found that chickens raised on ...pristine laboratory conditions have high levels of...

...results in an enhanced long-term memory, researche...l Cell, published by Cell Press. These findings po... drug to treat memory loss, according to the resea...ally increases levels of a natural memory-blocking...f this gene showed improved performance in classic...

Other Biology News:Changes in amino acids in the 1918 influenza virus cut transmission 2 Changes in amino acids in the 1918 influenza virus cut transmission 3 Study finds antibiotic resistance in poultry even when antibiotics were not used 2 Study finds antibiotic resistance in poultry even when antibiotics were not used 3 Mutation improves memory, may lead to memory-enhancing pill 2 Mutation improves memory, may lead to memory-enhancing pill 3

Changes in amino acids in the 1918 influenza virus cut transmission Study finds antibiotic resistance in poultry even when antibiotics were not used Mutation improves memory, may lead to memory-enhancing pill

CoverWell imaging chamber gasket with adhesive, one chamber, 20 mm diameter, 1.0 mm deep *set of 40* from Molecular Probes (Invitrogen)

Canine IL-10 ELISpot Development Kit from R&D Systems

Equine TNF ALPHA from AbD Serotec

DETACHaBEAD CD19 from Dynal Biotech

Biology Products:

CoverWell imaging chamber gasket with adhesive, one chamber, 20 mm diameter, 1.0 mm deep *set of 40* from Molecular Probes (Invitrogen)Canine IL-10 ELISpot Development Kit from R&D Systems Equine TNF ALPHA from AbD Serotec DETACHaBEAD CD19 from Dynal Biotech

Bucindolol Significantly Reduces Hospitalization and Death in Heart Failure Patients With Very Favorable...( Common Genetic Variations Predict P...)